199 related articles for article (PubMed ID: 23371439)
21. Clinical application of noninvasive prenatal testing for the detection of trisomies 21, 18, and 13: a hospital experience.
Zhou Q; Pan L; Chen S; Chen F; Hwang R; Yang X; Wang W; Jiang J; Xu J; Huang H; Xu C
Prenat Diagn; 2014 Nov; 34(11):1061-5. PubMed ID: 24899146
[TBL] [Abstract][Full Text] [Related]
22. Clinical evaluation of the IONA test: a non-invasive prenatal screening test for trisomies 21, 18 and 13.
Papageorghiou AT; Khalil A; Forman M; Hulme R; Mazey R; Mousa HA; Johnstone ED; McKelvey A; Cohen KE; Risley M; Denman W; Kelly B
Ultrasound Obstet Gynecol; 2016 Feb; 47(2):188-93. PubMed ID: 26493543
[TBL] [Abstract][Full Text] [Related]
23. [Trisomy 18 and 13 and triploidy: the best way to diagnosis].
Odeh M
Harefuah; 2014 Sep; 153(9):522-3, 559. PubMed ID: 25417487
[TBL] [Abstract][Full Text] [Related]
24. Performance of the neoBona test: a new paired-end massively parallel shotgun sequencing approach for cell-free DNA-based aneuploidy screening.
Cirigliano V; Ordoñez E; Rueda L; Syngelaki A; Nicolaides KH
Ultrasound Obstet Gynecol; 2017 Apr; 49(4):460-464. PubMed ID: 27981672
[TBL] [Abstract][Full Text] [Related]
25. [MODELS OF CLINICAL IMPLEMENTATION OF CELL FREE FETAL DNA IN THE MATERNAL SERUM SCREENING TEST-ANALYSIS].
Yankova M; Chaveeva P; Stratieva V
Akush Ginekol (Sofiia); 2015; 54(7):15-21. PubMed ID: 27025103
[TBL] [Abstract][Full Text] [Related]
26. Improved diagnostic accuracy by using secondary ultrasound markers in the first-trimester screening for trisomies 21, 18 and 13 and Turner syndrome.
Karadzov-Orlic N; Egic A; Milovanovic Z; Marinkovic M; Damnjanovic-Pazin B; Lukic R; Joksic I; Curkovic A; Mikovic Z
Prenat Diagn; 2012 Jul; 32(7):638-43. PubMed ID: 22570267
[TBL] [Abstract][Full Text] [Related]
27. DNA sequencing versus standard prenatal aneuploidy screening.
Bianchi DW; Parker RL; Wentworth J; Madankumar R; Saffer C; Das AF; Craig JA; Chudova DI; Devers PL; Jones KW; Oliver K; Rava RP; Sehnert AJ;
N Engl J Med; 2014 Feb; 370(9):799-808. PubMed ID: 24571752
[TBL] [Abstract][Full Text] [Related]
28. Prenatal screening for and diagnosis of aneuploidy in twin pregnancies.
Audibert F; Gagnon A; ;
J Obstet Gynaecol Can; 2011 Jul; 33(7):754-67. PubMed ID: 21749753
[TBL] [Abstract][Full Text] [Related]
29. The impact of first trimester screening and early fetal anomaly scan on invasive testing rates in women with advanced maternal age.
Hagen A; Entezami M; Gasiorek-Wiens A; Albig M; Becker R; Knoll U; Stumm M; Wegner RD
Ultraschall Med; 2011 Jun; 32(3):302-6. PubMed ID: 20972947
[TBL] [Abstract][Full Text] [Related]
30. First-trimester screening for chromosomal abnormalities by integrated application of nuchal translucency, nasal bone, tricuspid regurgitation and ductus venosus flow combined with maternal serum free β-hCG and PAPP-A: a 5-year prospective study.
Ghaffari SR; Tahmasebpour AR; Jamal A; Hantoushzadeh S; Eslamian L; Marsoosi V; Fattahi F; Rajaei M; Niroomanesh S; Borna S; Beigi A; Khazardoost S; Saleh-Gargari S; Rahimi-Sharbaf F; Farrokhi B; Bayani N; Tehrani SE; Shahsavan K; Farzan S; Moossavi S; Ramezanzadeh F; Dastan J; Rafati M
Ultrasound Obstet Gynecol; 2012 May; 39(5):528-34. PubMed ID: 21793085
[TBL] [Abstract][Full Text] [Related]
31. hCG in screening for aneuploidy: a possible role for its glycoforms?
Brun S; Leguy MC; Bruneel A; Fournier T; Anselem O; Guibourdenche J
Placenta; 2014 Jun; 35(6):425-7. PubMed ID: 24731729
[TBL] [Abstract][Full Text] [Related]
32. Diagnostic accuracy of random massively parallel sequencing for non-invasive prenatal detection of common autosomal aneuploidies: a collaborative study in Europe.
Stumm M; Entezami M; Haug K; Blank C; Wüstemann M; Schulze B; Raabe-Meyer G; Hempel M; Schelling M; Ostermayer E; Langer-Freitag S; Burkhardt T; Zimmermann R; Schleicher T; Weil B; Schöck U; Smerdka P; Grömminger S; Kumar Y; Hofmann W
Prenat Diagn; 2014 Feb; 34(2):185-91. PubMed ID: 24222400
[TBL] [Abstract][Full Text] [Related]
33. Positive predictive value estimates for cell-free noninvasive prenatal screening from data of a large referral genetic diagnostic laboratory.
Petersen AK; Cheung SW; Smith JL; Bi W; Ward PA; Peacock S; Braxton A; Van Den Veyver IB; Breman AM
Am J Obstet Gynecol; 2017 Dec; 217(6):691.e1-691.e6. PubMed ID: 29032050
[TBL] [Abstract][Full Text] [Related]
34. Are serum protein biomarkers derived from proteomic analysis useful in screening for trisomy 21 at 11-13 weeks?
Mastricci AL; Akolekar R; Kuppusamy R; Ahmed M; Nicolaides KH
Fetal Diagn Ther; 2011; 30(1):53-9. PubMed ID: 21422752
[TBL] [Abstract][Full Text] [Related]
35. Clinical experience and follow-up with large scale single-nucleotide polymorphism-based noninvasive prenatal aneuploidy testing.
Dar P; Curnow KJ; Gross SJ; Hall MP; Stosic M; Demko Z; Zimmermann B; Hill M; Sigurjonsson S; Ryan A; Banjevic M; Kolacki PL; Koch SW; Strom CM; Rabinowitz M; Benn P
Am J Obstet Gynecol; 2014 Nov; 211(5):527.e1-527.e17. PubMed ID: 25111587
[TBL] [Abstract][Full Text] [Related]
36. Non-invasive prenatal testing (NIPT): Europe's first multicenter post-market clinical follow-up study validating the quality in clinical routine.
Flöck A; Tu NC; Rüland A; Holzgreve W; Gembruch U; Geipel A
Arch Gynecol Obstet; 2017 Nov; 296(5):923-928. PubMed ID: 28887622
[TBL] [Abstract][Full Text] [Related]
37. Noninvasive prenatal testing in routine clinical practice--an audit of NIPT and combined first-trimester screening in an unselected Australian population.
McLennan A; Palma-Dias R; da Silva Costa F; Meagher S; Nisbet DL; Scott F
Aust N Z J Obstet Gynaecol; 2016 Feb; 56(1):22-8. PubMed ID: 26817523
[TBL] [Abstract][Full Text] [Related]
38. [Non-invasive prenatal diagnosis of the most common aneuploidies with cell-free fetal DNA in maternal serum--preliminary results].
Bijok J; Gorzelnik K; Massalska D; Ilnicka A; Pawłowska B; Zimowski JG; Kucińska-Chahwan A; Jakiel G; Roszkowski T
Ginekol Pol; 2014 Mar; 85(3):208-13. PubMed ID: 24783433
[TBL] [Abstract][Full Text] [Related]
39. Analysis of cell-free fetal DNA in maternal blood for detection of trisomy 21, 18 and 13 in a general pregnant population and in a high risk population - a systematic review and meta-analysis.
Iwarsson E; Jacobsson B; Dagerhamn J; Davidson T; Bernabé E; Heibert Arnlind M
Acta Obstet Gynecol Scand; 2017 Jan; 96(1):7-18. PubMed ID: 27779757
[TBL] [Abstract][Full Text] [Related]
40. Accuracy of non-invasive prenatal testing using cell-free DNA for detection of Down, Edwards and Patau syndromes: a systematic review and meta-analysis.
Taylor-Phillips S; Freeman K; Geppert J; Agbebiyi A; Uthman OA; Madan J; Clarke A; Quenby S; Clarke A
BMJ Open; 2016 Jan; 6(1):e010002. PubMed ID: 26781507
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
